Table 1.
Overview of cell viability by tissue characteristics
Cell viability by gender | |||
Gender | Male (n = 23) | Female (n = 21) | |
Viability (%) | 70.5 ± 19.2 | 72.7 ± 10.9 | |
Cell viability by liver tissue sample weight | |||
Tissue weight (g) | <50 g (n = 18) | 51–150 g (n = 13) | >150 g (n = 13) |
Viability (%) | 65.2 ± 12.3 | 77.9 ± 11.3** | 79.0 ± 8.90** |
Cell viability by patient age | |||
Age (years) | 32–48 (n = 7) | 49–60 (n = 10) | >60 (n = 27) |
Viability (%) | 73.0 ± 13.0 | 75.1 ± 12.0 | 69.9 ± 18.3 |
Cell viability by patient diagnosis | |||
Diagnosis | Benign/other (n = 10) | Primary/cholangio carcinoma (n = 5) | Colorectal metastisis (n = 29) |
Viability (%) | 78.2 ± 9.5 | 67.6 ± 16.9 | 69.05 ± 16.1 |
Cell viability by BMI | |||
BMI (kg/m2) | 18–24.9 (n = 24) | 25–29.9 (n = 11) | >30 (n = 8) |
Viability (%) | 71.6 ± 17.4 | 75.1 ± 9.4 | 66.4 ± 18.7 |
Cell viability by liver steatosis grade | |||
Steatosis grade (%) | No steatosis 0–5% (n = 24) | Mild steatosis 6–20% (n = 7) | Severe steatosis >20% (n = 8) |
Viability (%) | 73.7 ± 10.3 | 74.9 ± 11.1 | 69.4 ± 19.6 |
Viability data presented as mean ± SD
** P < 0.01 for comparison of tissue weights >50 g versus all tissue weights <50 g